Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2015 in Pharmaceuticals

Be the first to review this product

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2015 in Pharmaceuticals

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for December...
You can choose to pay by purchase order during checkout

Availability: In stock

$1,000.00

* Required Fields

You can choose to pay by purchase order during checkout
GlobalData.

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2015 in Pharmaceuticals

Summary

GlobalData's 'Partnerships, Licensing, Investments and M&A Deals and Trends for December 2015 in Pharmaceuticals' report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in December 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Additional Information

Additional Information

Publisher name GlobalData.
Format PDF
Page count 99
Publication date 1 Feb 2016
Table of contents 1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2015 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2015 14
2.2.1 AstraZeneca to Acquire 55% Stake in Acerta Pharma 14
2.2.2 Gilead Sciences Enters into Co-Development Agreement with Galapagos 15
2.2.3 Xinjiang Tianshan Wool Tex Stock to Acquire Beijing Jialin Pharma for USD1.3 Billion 16
2.2.4 Pfizer Enters into Licensing Agreement with BioAtla 16
2.2.5 ViiV Healthcare to Acquire HIV R&D Assets of Bristol-Myers Squibb for up to USD835 Million 16
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2015 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2015 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2015 20
3.1.1 Top M&A Deals in December 2015 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2015 - December 2015 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2015 24
3.2.1 Top Equity Offering Deals in December 2015 25
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2015 - December 2015 26
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2015 28
3.3.1 Top PE/VC Deals in December 2015 29
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2015 30
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2015 31
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2015-December 2015 33
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2015-December 2015 34
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2015 35
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2015 35
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2015 - December 2015 37
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2015 38
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2015 39
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2015 - December 2015 40
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2015 - December 2015 42
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2015 - December 2015 43
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2015 - December 2015 45
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2015 47
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2015 47
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2015 49
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2015 - December 2015 51
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2015 - December 2015 52
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2015 - December 2015 54
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2015 - December 2015 56
5.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2015 57
5.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2015 58
5.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2015 59
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 60
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2015 60
6.1.1 Oncology - Deals of the Month 61
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2015 63
6.2.1 Central Nervous System - Deals of the Month 64
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2015 65
6.3.1 Infectious Diseases - Deals of the Month 66
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2015 68
6.4.1 Cardiovascular - Deals of the Month 69
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2015 71
6.5.1 Immunology - Deals of the Month 72
6.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, December 2015 75
6.6.1 Gastrointestinal - Deals of the Month 76
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, December 2015 78
6.7.1 Metabolic Disorders - Deal of the Month 79
7 Deal Summary by Geography 81
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2015 81
7.1.1 North America - Deals of the Month 82
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2015 84
7.2.1 Europe - Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2015 87
7.3.1 Asia-Pacific - Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2015 90
7.4.1 Rest of the World - Deals of the Month 91
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 92
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2015 - December 2015 92
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2015 - December 2015 94
9 Further Information 96
9.1 Methodology 96
9.2 About GlobalData 97
9.3 Disclosure information 97
9.4 Disclaimer 98

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.